Successful ABO-incompatible kidney transplantation with antibody removal and standard immunosuppression

American Journal of Transplantation

Volumn 11, Issue 5, 2011, Pages 1016-1024

  Flint, S M ^a   Walker, R G ^a   Hogan, C ^a   Haeusler, M N ^a   Robertson, A ^a   Francis, D M A ^a   Millar, R ^a   Finlay, M ^a   Landgren, A ^a   Cohney, S J ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

ABO incompatible; immunosuppression; plasma exchange; renal transplantation

Indexed keywords

BASILIXIMAB; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; ANTIBODY RESPONSE; ARTICLE; BIOPSY TECHNIQUE; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PLASMAPHERESIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL;

ABO BLOOD-GROUP SYSTEM; ADULT; BIOPSY; BLOOD GROUP INCOMPATIBILITY; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 79955526438     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03464.x     Document Type: Article

References (33)

1. Wolfe RA, Ashby VB, Milford EL, et al,. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
2. Rydberg L,. ABO-incompatibility in solid organ transplantation. Transfus Med 2001; 11: 325-342. (Pubitemid 32771925)
3. Grim SA, Pham T, Thielke J, et al,. Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients. Clin Transplant 2007; 21: 628-632. (Pubitemid 47399427)
4. Rydberg L, Breimer ME, Samuelsson BE, Brynger H,. Blood group ABO-incompatible (A2 to O) kidney transplantation in human subjects: A clinical, serologic, and biochemical approach. Transplant Proc 1987; 19: 4528-4537. (Pubitemid 18049655)
5. Squifflet JP, De Meyer M, Malaise J, Latinne D, Pirson Y, Alexandre GP,. Lessons learned from ABO-incompatible living donor kidney transplantation: 20 years later. Exp Clin Transplant 2004; 2: 208-213.
6. Takahashi K, Saito K, Takahara S, et al,. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004; 4: 1089-1096. (Pubitemid 38868599)
7. Tanabe K,. Japanese experience of ABO-incompatible living kidney transplantation. Transplantation 2007; 84 (12 Suppl): S4-S7.
8. Jordan SC, Reinsmoen N, Peng A, et al,. Advances in diagnosing and managing antibody-mediated rejection. Pediatr Nephrol 2010; 25: 2035-2048.
9. Gloor J, Stegall M,. ABO-incompatible kidney transplantation with and without splenectomy. Transplantation 2006; 82: 720. (Pubitemid 44395252)
10. Genberg H, Kumlien G, Wennberg L, Berg U, Tyden G,. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: A 3-year follow-up. Transplantation 2008; 85: 1745-1754.
11. Cohney SJ, Walker RG, Haeusler MN, Francis DM, Hogan CJ,. Blood group incompatibility in kidney transplantation: Definitely time to re-examine! Med J Aust 2007; 187: 306-308.
12. Montgomery RA, Locke JE, King KE, et al,. ABO incompatible renal transplantation: A paradigm ready for broad implementation. Transplantation 2009; 87: 1246-1255.
13. Tydén G, Kumlien G, Fehrman I,. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 2003; 76: 730-731. (Pubitemid 37072012)
14. Australian & New Zealand Society of Blood Transfusion Ltd, Royal Australian & New Zealand College of Obstetricians & Gynaecologists. Guidelines for blood grouping & antibody screening in the antenatal & perinatal setting. Sydney, 2007 (available from).
15. Marsh WL,. Scoring of hemagglutination reactions. Transfusion 1972; 12: 352-353.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D,. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
17. Cohney S, Flint S, Hughes P, Masterson R, Haeusler M, Hogan C,. Successful ABO-incompatible renal transplantation with conventional immunosuppression alone-no splenectomy, no rituximab and no antibody removal [abstract]. Am J Transplant 2009; 9 (2 Suppl): 220.
18. Gloor J, Lager D, Fidler M, et al,. A comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation. Transplantation 2005; 80: 1572-1577. (Pubitemid 43005868)
19. Tobian AA, Shirey RS, Montgomery RA, et al,. ABO antibody titer and risk of antibody-mediated rejection in ABO-incompatible renal transplantation. Am J Transplant 2010; 10: 1247-1253.
20. Tobian AA, Shirey RS, Montgomery RA, Ness PM, King KE,. The critical role of plasmapheresis in ABO-incompatible renal transplantation. Transfusion 2008; 48: 2453-2460.
21. Kumlien G, Wilpert J, Safwenberg J, Tyden G,. Comparing the tube and gel techniques for ABO antibody titration, as performed in three European centers. Transplantation 2007; 84 (12 Suppl): S17-S19.
22. Flint S, Greenall J, Masterson R, et al,. Splenectomy as a treatment for antibody-mediated rejection [abstract]. Nephrology 2007; 12 (2 Suppl): A1059.
23. Wasserstrom H, Bussel J, Lim LC, Cunningham-Rundles C,. Memory B cells and pneumococcal antibody after splenectomy. J Immunol 2008; 181: 3684-3689.
24. Leandro MJ, de la Torre I,. Translational mini-review series on B cell-directed therapies: The pathogenic role of B cells in autoantibody- associated autoimmune diseases-lessons from B cell-depletion therapy. Clin Exp Immunol 2009; 157: 191-197.
25. Kaposztas Z, Podder H, Mauiyyedi S, et al,. Impact of rituximab therapy for treatment of acute humoral rejection. Clin Transplant 2009; 23: 63-73.
26. Faguer S, Kamar N, Guilbeaud-Frugier C, et al,. Rituximab therapy for acute humoral rejection after kidney transplantation. Transplantation 2007; 83: 1277-1280. (Pubitemid 46743692)
27. Mulley WR, Hudson FJ, Tait BD, et al,. A single low-fixed dose of rituximab to salvage renal transplants from refractory antibody-mediated rejection. Transplantation 2009; 87: 286-289.
28. Tinckam KJ, Wood IG, Ji F, Milford EL,. ATG induction is associated with an increase in anti-HLA antibodies after kidney transplantation. Hum Immunol 2004; 65: 1281-1287. (Pubitemid 39535291)
29. Muthukumaraswamy S, Cornell L, Kremers W, Stegall M, Gloor J,. Association between antidonor blood group antibody titer and acute humoral rejection (AHR) in ABO incompatible kidney transplantation [abstract]. Am J Transplant, 2009; 9 (2 Suppl) 415.
30. Sivakumaran P, Vo AA, Villicana R, et al,. Therapeutic plasma exchange for desensitization prior to transplantation in ABO-incompatible renal allografts. J Clin Apher 2009; 24: 155-160.
31. Galliford J, Chan K, Lawrence C, et al,. Antibody mediated rejection after ABO incompatible living donor renal transplantation is mainly associated with HLA donor specific antibodies [abstract]. Am J Transpl, 2010; 10 (4 Suppl): 164.
32. Tydén G, Kumlien G, Genberg H, et al,. The Stockholm experience with ABO-incompatible kidney transplantations without splenectomy. Xenotransplantation 2006; 13: 105-107.
33. Ishida H, Miyamoto N, Shirakawa H, et al,. Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation-single center analysis. Am J Transplant 2007; 7: 825-831. (Pubitemid 46481177)